Price
No data yet.
Social Signal Score
Analyst Ratings
32 analystsRevenue
$5.63B+16.07%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Saumya Sutaria
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 88,500
- Beta
- 1.23
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 2.09
Financials
Revenue
$5.63B+16.1%Net Income
$826.00MEBITDA
$1.24B+130.7%Free Cash Flow
$417.00M+513.2%EPS (diluted)
$9.84Shares Outstanding (diluted)
83.96M-15.6%Operating Expenses
$2.23BCash & Debt
$2.17BReturn of Capital
$1.04BRevenue by Segment (annual)
$10.30BDividend per Share
$0.03Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $21.31B | $1.41B | $15.61 |
| 2024 | $20.66B | $3.20B | $33.02 |
| 2023 | $20.55B | $611.00M | $6.01 |
| 2022 | $19.17B | $411.00M | $3.84 |
| 2021 | $19.48B | $914.00M | $8.55 |
| 2020 | $17.64B | $399.00M | $3.80 |
| 2019 | $18.48B | $-215.00M | $-2.24 |
| 2018 | $18.31B | $104.00M | $1.09 |
| 2017 | $19.18B | $-704.00M | $-7.00 |
| 2016 | $19.62B | $-192.00M | $-1.93 |
| 2015 | $18.63B | $-140.00M | $-1.41 |
| 2014 | $16.60B | $12.00M | $0.12 |
| 2013 | $11.09B | $-134.00M | $-1.32 |
| 2012 | $9.12B | $152.00M | $1.35 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from THC's reported EPS growth of 20.7% a year over 13 years.
- EPS in 5 years
- $39.98
- Implied price
- $519.77
- Return from $258.62
- 15.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $258.42 — -0.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 9 | 11 | 13 | 15 | 17 |
|---|---|---|---|---|---|
| 10.7% | -2.0% | 2.0% | 5.5% | 8.5% | 11.3% |
| 15.7% | 2.4% | 6.6% | 10.2% | 13.4% | 16.3% |
| 20.7% | 6.8% | 11.2% | 15.0% | 18.3% | 21.3% |
| 25.7% | 11.3% | 15.8% | 19.7% | 23.2% | 26.3% |
| 30.7% | 15.7% | 20.4% | 24.5% | 28.1% | 31.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50-28.57%Social Signal Score
Mentions (34)
- News (RSS)fortune·1d ago·Neutral
Sen. Mitch McConnell closed a loophole in a hemp law he championed. Now a $28 billion THC industry that gets people high is fighting for survival The industry hopes to save itself by restricting impairing products to people 21 and older, limiting how much THC can be in a package, and banning imported cannabis compounds.
View source ↗ - Newszacks.com·3d ago·Neutral
Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know Tenet Healthcare (THC) reached $258.62 at the closing of the latest trading day, reflecting a +1.83% change compared to its last close.
View source ↗ - Newszacks.com·5d ago·Positive
Can THC's Cash Flow Support Its Expanding Capital-Return Strategy? Tenet Healthcare's stronger cash flow is fueling bigger buybacks, but growth investments and capital needs will test how sustainable its strategy is.
View source ↗ - Newszacks.com·5d ago·Positive
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - News (RSS)zerohedge·8d ago·Neutral
…desperately needing something to stop their vomiting and fire their appetites. And nothing works better for this than smoking marijuana. The feds approved pills with THC, the active ingredient in marijuana; however, pills are scant help to someone heaving their guts. Bluster from Washington political hacks failed to stop the cascade of new scientific evidence on the medicinal benefits of marijuana: A 1997 study performed on animals at the University of California at San Francisco found that cann…
View source ↗ - 4chan /biz/biz·11d ago·Neutral
>>62724482 >makes me paranoid you're smoking a turbo modified THC strain with little to no CBD to control it.
View source ↗ - Newszacks.com·11d ago·Neutral
Can Tenet Healthcare Sustain Growth Despite Lower Surgical Volumes? THC's revenue growth persists despite softer surgical volumes, driven by higher revenue per case, acuity and favorable service mix.
View source ↗ - Newszacks.com·12d ago·Neutral
Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to Note In the latest trading session, Tenet Healthcare (THC) closed at $256.44, marking a -2.14% move from the previous day.
View source ↗ - News (Marketaux)gurufocus.com·13d ago·Positive
THC Looks 41.3% Overvalued on GF Value™ On September 22, 2026, BMO Capital initi[+293 characters]
View source ↗ - News (RSS)fool·16d ago·Negative
Tenet Healthcare Director Nadja West Sells 1,152 Shares After the sale, West still held $6.1 million in stock.
View source ↗ - Newsfool.com·16d ago·Negative
Tenet Healthcare Director Nadja West Sells 1,152 Shares The insider executed a sale of 1,152 shares at $258.80 per share. The transaction involved shares equal to 5% of the equity stake held directly by the insider prior to the filing.
View source ↗ - Newszacks.com·20d ago·Neutral
Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to Note Tenet Healthcare (THC) closed the most recent trading day at $260.85, moving 1.38% from the previous trading session.
View source ↗ - 4chan /biz/biz·20d ago·Neutral
THC INFUSED COFFEE they might be on to something big here.
View source ↗ - Newszacks.com·20d ago·Positive
Is Tenet (THC) a Solid Growth Stock? 3 Reasons to Think "Yes" Tenet (THC) possesses solid growth attributes, which could help it handily outperform the market.
View source ↗ - Newszacks.com·20d ago·Neutral
Wall Street Analysts Think Tenet (THC) Is a Good Investment: Is It? Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
View source ↗ - Newszacks.com·21d ago·Positive
Here's Why Tenet Healthcare Shares are Attracting Investors Now THC's shares are gaining on higher-acuity demand, strong commercial revenues and USPI's continued expansion.
View source ↗ - PodcastAll In·24d ago·Positive
EY and Deloitte because we're like, hey, let's find a way to help solve these problems in advance. And initially, when, when we would go and talk to a bunch of companies, they would be like, oh, we did the ZDR thing. And we're like, okay, well, we'll just keep educating you and five or six months, you'll realize that ZDR means literally nothing. And it's flimsy and it's Swiss cheese. And now, all these companies are coming back to EY and Deloitte and us and they're like, oh, my God, fix the prob
View source ↗ - Newszacks.com·24d ago·Positive
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - Newsseekingalpha.com·26d ago·Positive
Tenet Healthcare Corporation (THC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript Tenet Healthcare Corporation (THC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
View source ↗ - News (RSS)investing·27d ago·Neutral
Tenet Healthcare prices $2 billion senior notes offering
View source ↗ - Newsbusinesswire.com·27d ago·Negative
Tenet Announces Upsizing and Pricing of Its $2.0 Billion Private Offering of Senior Notes DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $2.0 billion in aggregate principal amount of senior notes due on September 15, 2034, which will bear interest at a rate of 6.250% per annum (the “notes”). The aggregate principal amount of notes to be issued in the offering was…
View source ↗ - Newszacks.com·28d ago·Positive
Why Tenet Healthcare (THC) is a Top Momentum Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
View source ↗ - News (RSS)zerohedge·31d ago·Negative
…abis edibles. Conducted in a Canadian hospital, the study analyzed data of 40 people aged 19-45 years. They received gummies containing delta-9-tetrahydrocannabinol (THC) - the main psychoactive chemical in cannabis that causes brain-altering effects. Various combinations of THC and placebo edibles were given to achieve four doses of THC exposure - 0 mg, 2 mg, 10 mg, and 20 mg. The study measured the standard deviation of lateral position (SDLP), which assesses how drivers adjust lane position a…
View source ↗ - Newszacks.com·31d ago·Positive
Fast-paced Momentum Stock Tenet (THC) Is Still Trading at a Bargain Tenet (THC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
View source ↗ - Newscnbc.com·32d ago·Negative
THC drinks could soon be harder to find as Congress delays hemp ban again THC drinks are booming, but a looming federal crackdown threatens the industry. THC beverages generated $239 million in measured U.S. retail sales in the 52 weeks through April, up 135% from a year earlier, according to NielsenIQ.
View source ↗ - News (RSS)venturebeat·39d ago·Neutral
Visa ships a security AI that patches production code before any human reviews it Visa's open-source security harness now finds the vulnerability, writes the fix, and turns an adversarial panel on its own patch before any human reviews it. The whole loop ships on by default. A plain scan of the Visa Vulnerability Agentic Harness runs all 11 stages and edits source files in the target repo unless the operator caps it at detection.The announcement Thursday pairs the release with an expansion of th
View source ↗ - News (RSS)financialpost·40d ago·Neutral
ThreeD Capital Inc. Congratulates Tenet Fintech Group Inc. On Its Second Quarter 2026 Financial Results TORONTO, Aug. 26, 2026 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, congratulates Tenet Fintech Group Inc. (“Tenet”) on its second quarter 2026 financial results. Tenet is an innovative analytics serv
View source ↗ - News (RSS)venturebeat·40d ago·Neutral
The fix for the AI agent that hijacked a company's DNS: it can propose the change, but it can't approve it A security agent read a Cloudflare log, found an attacker’s prompt-injection payload sitting inside it, and rewrote the company’s DNS. The firewall had already blocked that payload, and blocking it is what wrote it into the log.That chain is GhostJacking, which Tenet Security demonstrated on the DEF CON 34 main stage on August 9. A request hits Cloudflare’s managed ruleset, gets blocked, an
View source ↗ - Newsprnewswire.com·40d ago·Neutral
Horticulture Co., a Leading U.S. Beverage Company focused on Hemp-Derived THC and Functional Adult Beverages, Sees Tremendous Success From 112.5% YoY Growth to Expansion into New Markets, Securement of New Retailers Including ABC Fine Wine & Spirits, Sprouts, and BP Thorntons to Celebrity Partnerships Of-Note with the Likes of NBA Legends Allen Iverson and Al Harrington /PRNewswire/ -- Today, Horticulture Co., a leading U.S. beverage company focused on hemp-derived THC and functional adult bever…
View source ↗ - Newszacks.com·42d ago·Neutral
Tenet (THC) is an Incredible Growth Stock: 3 Reasons Why Tenet (THC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
View source ↗ - News (RSS)yahoo·43d ago·Positive
Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?
View source ↗ - Newszacks.com·49d ago·Neutral
Can Tenet Healthcare's Hospital Growth Keep Earnings Momentum Going? THC's hospital growth is fueling earnings momentum as stronger volumes, revenues and margins help offset exchange weakness.
View source ↗ - Newszacks.com·52d ago·Positive
Tenet Healthcare Corporation (THC) Hits Fresh High: Is There Still Room to Run? Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
View source ↗ - Newszacks.com·54d ago·Positive
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
View source ↗
Earnings
Thu, Oct 29(in 3 weeks)
Consensus estimate $4.67 per share
Typical surprise +16.6% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 23$6.12 vs $4.26beat
- Thu, Apr 30$4.82 vs $4.17beat
- Wed, Feb 11$4.70 vs $4.07beat
- Tue, Oct 28$3.70 vs $3.34beat
- Tue, Jul 22$4.02 vs $2.87beat
- Tue, Apr 29$4.36 vs $3.12beat
Estimates and results for THC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by THC officers and directors.
- Bought
- —
- Sold
- $55.0m
0 trades
28 trades
- Kerrey J Robertsold
- Kerrey J Robertsold
- Kerrey J Robertsold
- Mark Richard Jsold
- West Nadjasold
- Foo Lisa Ysold
- Sutaria Saumyasold
- Sutaria Saumyasold
72 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Jonathan Jacksonhouse · IL01 · disclosed May 28, 2026 (38d later)Sell$15,001 - $50,000
- Jonathan Jacksonhouse · IL01 · disclosed May 28, 2026 (43d later)Sell$1,001 - $15,000
- Jonathan Jacksonhouse · IL01 · disclosed Mar 13, 2026 (30d later)Sell$1,001 - $15,000
- Jonathan Jacksonhouse · IL01 · disclosed Jan 9, 2026 (30d later)Buy$15,001 - $50,000
- Jonathan Jacksonhouse · IL01 · disclosed Oct 16, 2025 (43d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (42d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (63d later)Buy$1,001 - $15,000
- John Jameshouse · MI10 · disclosed Sep 6, 2024 (2d later)Sell$1,001 - $15,000
- John Jameshouse · MI10 · disclosed Sep 2, 2024 (297d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.